Trial intelligence / Profile preview

Zemplar vs Hectorol Calcium Absorption in CKD

NCT00257920Phase 4Completed

Sponsor
Abbott Laboratories
Start
Jun 2006
Primary completion
Jan 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of paricalcitol in secondary hyperparathyroidism (SHPT), sponsored by Abbott Laboratories. Started Jun 2006; status: completed.

02

Drugs

paricalcitol
03

Conditions

secondary hyperparathyroidism (SHPT)

Beyond the preview

Go deeper on NCT00257920.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00257920.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call